It is currently Mon Jun 26, 2017 7:06 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Exercises and limited mobility?

My mom's in the wheelchair.

How can she do cardio?

Or does she need to take bisphosphonate?
Read more : Exercises and limited mobility? | Views : 203 | Replies : 3 | Forum : Coimbra High-Dose Vitamin D Protocol


Hugo Macia recently wrote on the website « To really treat MS one must first treat the psychological issue, or better yet, treat both the physical and psychological issues together ». Hugo’s native tongue is Spanish, I have revised the English to facilitate understanding for English speakers. No offense to Hugo I hope.***

The psychological question in MS is often a touchy issue. However, it shouldn’t be. Everyone has a psychology and every pathology ...
Read more : MS PSYCHOLOGY? | Views : 153 | Replies : 0 | Forum : General Discussion

MRI and lesions

Hi, I read on certain forums that MS lesions tend to only appear on MRIs after about 6 months. Is that true? I had a variety of neurological symptoms that started in January, and had MRIs (brain and full spine) and EVP (sensomatory) in late May. Everything was clear, but now I am thinking that maybe it was far too early to see anything? The brain MRI used a contrast agent. Thank you in advance! ...
Read more : MRI and lesions | Views : 219 | Replies : 3 | Forum : General Discussion


HI Friends please read ... isk-of-ms/

A recent study reported at ECTRIMS (European Committee for Treatment and Research in MS) in Barcelona reports that higher intake of plant-based essential fatty acids, such as alpha linolenic acid in flaxseed oil, may reduce the risk of developing Multiple Sclerosis.

Examining data from the Nurses Health Study on nearly 180,000 nurses in the US, investigators found that individuals who consumed the ...
Read more : RE PLANT BASED FATTY ACIDS MAY LOWER RISK OF M.S | Views : 133 | Replies : 0 | Forum : Natural Approach

Seasonal diet - Asparagus benefits for MS?

Where I live, we're in the thick of asparagus season (and on the tail end of fiddlehead season ... well, in the grocery store at least - according to reports, in the local wilds the fiddleheads are long gone).

Picked up two bunches of asparagus yesterday, probably bunches #9 and #10 of the season. Since i eat it only on a local seasonal basis, asparagus has not tended to make it into any of my ...
Read more : Seasonal diet - Asparagus benefits for MS? | Views : 170 | Replies : 1 | Forum : Diet


A friend suggested learning about it for my PPMS. A clinical trial has almost ended, I believe.
Read more : Ibudilast | Views : 163 | Replies : 1 | Forum : General Discussion

Stressful Environment Triggers Inflammatory Cells Linked to

Stressful Environment Triggers Inflammatory Cells Linked to Autoimmune Diseases Like MS, Study Shows

A stressful microenvironment, characterized by low metabolites and low oxygen levels, triggers the generation of immune cells directly implicated in a variety of inflammatory diseases, such as multiple sclerosis (MS).

The study, “Cellular Stress in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 Differentiation,” was published in the journal Cell Reports.

Immune cells are vital players defending our organism ...

Sodium intake not linked to MS progression

Researchers have conducted a study into whether a high-salt diet is associated with faster conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS) MS activity and disability. This was measured by urinary sodium concentration...Read more -
Read more : Sodium intake not linked to MS progression | Views : 184 | Replies : 0 | Forum : General Discussion

Unpublished data may explain Lemtrada's efficacy...

Previously unpublished data may explain Lemtrada's efficacy and side effects

Analysis of previously unpublished data from the pivotal phase III trials in the regulatory submissions of alemtuzumab, otherwise known as Lemtrada, indicated that efficiency was associated with long-term depletion of memory T- and B-cells. Whereas rapid hyper-repopulation of immature B-cells in the relative absence of regulatory CD4 and CD8 T-cells create the environment for the generation of secondary B-cell autoimmunity, including anti-drug antibodies...Read more - ...


Login  •  Register


Total posts 238561 • Total topics 25981 • Total members 17249

Contact us | Terms of Service